Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

New York Times columnist and former Nixon speechwriter William Safire is the latest prominent conservative to endorse embryonic stem cell research. Yesterday, Safire devoted his column to his hope that former president Ronald Reagan’s long battle with Alzheimer’s may help to break the impasse blocking greater federal support of research into the cells and their potential to help millions of American’s including those with Alzheimer’s.

Safire cogently argues that

this research, whether the government likes it or not, is growing apace. Unless we act now to direct it toward morally acceptable ends–cure and treatment of disease and the extension of active life, not monstrous manipulation and production of clones for spare parts–we risk losing the imperfectability that makes us human.
This is the point that many opponents of stem cell research miss: that by not funding embryonic stem cell research, which will continue regardless, the federal government misses its chance to effectively shape and regulate the direction that research takes.

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me